Scientists for EU launch Healthier in the EU campaign

Dear Editor,

On 3rd March, Scientists for EU will launch their campaign, Healthier in the EU, and I am proud to be on their advisory board.

The positive impact that EU membership has on our health is often overlooked.  But …

continue reading —

East Midlands MEP calls for the EU to do more on cancer research

laboratory large

An East Midlands MEP has called on the EU to support more research and development of new treatments for cancer. The EU has a £54 billion fund, Horizon 2020, to support research and innovation.

Glenis Willmott, Labour MEP for the …

continue reading —

Raising Awareness of Rare Diseases in Europe

Glenis and Vytenis Andriukaitis 2Saturday 28th February is European Rare Disease Day 2015, which aims to raise awareness of rare diseases and the impact they have on the lives of people who suffer from them.

A rare disease affects fewer than 5 in …

continue reading —

Labour MEP named Policy Maker of the Year for work on rare diseases

Bruxelles: EURORDIS Black Pearl GALA DINNER 2015.A Labour MEP has won an award for her work to help improve the lives of people with rare diseases in Europe.

Last night, Glenis Willmott MEP, Labour’s European spokesperson on health, was presented with the Policy Maker of the …

continue reading —

Local MEP to chair health group in Europe

gw picA local MEP has been chosen to chair the European Parliament’s Health Working Group.

Labour MEP Glenis Willmott was re-elected as co-chair of the group, which works to give members of the European Parliament access to research and expert advice …

continue reading —

Labour MEP receives Outstanding Leadership Award

IMAG2014Glenis Willmott, Labour MEP for the East Midlands, will today receive the Award for Outstanding Leadership from the Belgian Association of Clinical Researchers. The award recognises Ms Willmott’s extensive work on encouraging medical research and ensuring full transparency of clinical …

continue reading —

Reaction to European Medicine Agency’s transparency policy

ClinicalTrialsGlenis Willmott MEP, rapporteur for the Clinical Trials Regulation has commented following the meeting of the European Medicines Agency (EMA) on the publication of clinical trials data.

“I am pleased to see the idea of ‘screen-only’ viewing of clinical trial …

continue reading —

New EU clinical trial rules will ensure Tamiflu scandal won’t happen in future

clinical trials microscopeNew clinical trials transparency measures, voted through by the European Parliament last week, will prohibit companies from suppressing data and putting lives at risk.

This week it was revealed Roche, the drug company behind Tamiflu, withheld vital information on its …

continue reading —

Pharma company drops transparency challenge following new Labour-led law

ClinicalTrialsJust one day after the European Parliament approved transparency measures for clinical trials, pharmaceutical company AbbVie have announced they are dropping their court case against the European Medicines Agency for attempting to publish clinical trial data.

Glenis Willmott MEP steered …

continue reading —